Market capitalization | SEK8.21b |
Enterprise Value | SEK8.22b |
P/E (TTM) P/E ratio | 46.90 |
EV/FCF (TTM) EV/FCF | 17.42 |
EV/Sales (TTM) EV/Sales | 6.90 |
P/S ratio (TTM) P/S ratio | 6.89 |
P/B ratio (TTM) P/B ratio | 10.13 |
Dividend yield | 1.25% |
Last dividend (FY24) | SEK3.00 |
As a Free StocksGuide user, you can view scores for all 6,815 stocks worldwide.
1 Analyst has issued a forecast RaySearch Laboratories:
1 Analyst has issued a forecast RaySearch Laboratories:
Dec '24 |
+/-
%
|
||
Revenue | 1,192 1,192 |
17%
17%
|
|
Gross Profit | 1,093 1,093 |
62%
62%
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 247 247 |
105%
105%
|
Net Profit | 204 204 |
149%
149%
|
In millions SEK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. Its products and services are divided into three categories: RayStation, Partner Products, and Research. RayStation is the company's proprietary treatment planning system. Partner Products include proton and intensity modulated radiation therapy, automatic treatment planning, quality assurance, and radiobiology. Research offers long term study of new methods and techniques in radiation treatment. The company was founded by Johan Löf, Erik Hedlund, Carl Filip Bergendal, Anders Brahme, Bengt Lind, and Anders Liander in 2000 and is headquartered in Stockholm, Sweden.
Head office | Sweden |
CEO | Johan Löf |
Employees | 416 |
Founded | 2000 |
Website | www.raysearchlabs.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.